It has been argued that today's prescription durg market originated in the arbitrary acts of the US Food and Drug Administration (FDA), which in 1938 issued regulations creating a class of drugs that could be sold by prescription only.
On the basis of the FDA's administrative records, I argue that the 1938 regulations on prescription drug labeling were initiated by industry and then agreed to by the FDA ; that contemporaries understood and accepted the reasons for restricting the use of certain drugs ; and that the subsequent evolution of the regulations is best understood as an FDA effort to limit industry abuses of the prescription labeling system.
This decade-long war of position ended when drug manufacturers persuaded the US Congress to enshire their version of prescription labeling in law in a highly politicized struggle over governement's role in the economy.
Mots-clés Pascal : Législation, Food and Drug Administration, Prescription médicale, Médicament, Historique, Industrie pharmaceutique, Etats Unis, Article synthèse, Délivrance sur ordonnance, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Legislation, Food and Drug Administration, Medical prescription, Drug, Case history, Pharmaceutical industry, United States, Review, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0209001
Code Inist : 002B30A09. Création : 09/06/1995.